Psychedelic Drugs: Regulators Still Unsure On Development Path, But Willing To Listen

 
• By Derrick Gingery

Potential sponsors have many questions to answer, but have a unique opportunity to influence policy for a new therapy area.

mushrooms
An EMA official said sponsors may have to think out of box in designing psychedelic clinical trials. • Source: Shutterstock

More from Clinical Trials

More from Conferences